Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Obesity

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

With Obesity Drug Demand Surging, Is Novo Nordisk a Buy?

Novo Nordisk (NVO) continues strengthening its obesity portfolio and marking new milestones. The company’s solid product demand, strategic investments, and developments are the key drivers for its growth and success. So, let’s examine whether NVO is an ideal investment choice. Read more to find out.

StockNews.com

Junk food ads to be banned pre-watershed from next year

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

NHS restricting access to obesity services across England, BMJ finds

Budget cuts to local services fell disproportionately on care for obese patients, leading to ‘postcode lottery’

The Guardian - UK

'Removing blame': New weight-loss drug for obesity and overweight people

First there was Ozempic, then Wegovy, now we have Mounjaro.

Newcastle Herald

Liraglutide: Weight loss drug found to be 'safe and effective' for children aged under 12

Daily injection found to reduce body mass index and improve blood pressure in children between ages of 6 and 12

Evening Standard

Weight-loss drug Saxenda effective for kids as young as 6, study shows

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with diet and exercise

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

PCOS leads to diabetes, inflammation and infertility

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine gland illnesses in women, with an incidence range from 10% to 20 % in India. Patients experiencing PCOS experience issues involving irregular menstrual periods, hirsutism, acne, being overweight, and infertility. Long-term, low-grade inflammation has emerged as a crucial factor…

The Times of India

8 fibre-rich foods to shed belly fat

Shedding belly fat is considered a herculean task and without a proper strategy it's difficult to lose this pesky fat. One of the most effective ways to target that stubborn belly fat is eating a healthy diet. Consuming a fibre-rich diet can help boost your overall well-being and also aid…

The Times of India

The modern epidemic: How sedentary lifestyles are fuelling cancer

Cancer incidences are rising globally. Variations in the metabolism of nutrients, including fatty acids, amino acids, and glucose, are linked to an increased risk of cancer. Numerous cancer forms have been related to obesity and overweight. There is strong evidence that aerobic physical activity, including walking, can help you maintain…

The Times of India

Saying goodbye to obesity: Weighing the options

When obesity poses greater health risk with higher fat percentage, doctors consider bariatric surgery as a viable treatment option.

The Times of India

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?

Analysis: It’s been heralded as the ‘fountain of youth’ that could cure heart problems and promote rapid weight loss, but could Ozempic change all our lives, asks Rebecca Thomas

The Independent UK

TOI Medithon: Experts joined to discuss risks, complications, prevention and how to live well with diabetes

Diabetes can profoundly impact life. It may lead to dietary restrictions, affecting social and eating habits. The risk of complications such as heart disease, neuropathy, and vision problems can necessitate frequent lifestyle adjustments.

The Times of India

Most baby foods sold in the US high in sugar, low in protein; fail to meet nutrition standards

A new study has found that a staggering 60 percent of baby food sold in the United States doesn't meet WHO's nutritional standards, and could be affecting children's health.

The Times of India

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

2nd TOI Medithon: Experts discuss risks, complications, prevention and how to live well with diabetes

Medical Daily

Obesity Raises Risk Of COVID Infection By 34%: Study Says

The study suggests that obesity not only worsens the outcomes of COVID but also increases the risk for infection upon exposure.

International Business Times

Eli Lilly Launches Discount Anti-Obesity Drug

The company claims the Zepbound doses cost 50% less than competing drugs

International Business Times UK

10 Things Americans Love Eating That Are Banned In Other Countries

Consumers in the US put their trust in organizations such as the Food and Drug Administration to keep foods, fish, and livestock safe - but to what standards?

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The simple sandwich filler linked with a 15% higher risk of type 2 diabetes

Researchers say the findings back the recommendations to reduce meat intake

Salon

Support for processed food taxes grows

Participants of a survey conducted by Ipsos said the taxes would help combat the country’s obesity crisis

The Times of India

Cancer in millennials rising; top lifestyle changes to cut cancer risk

Cancer cases are rising exponentially among millennials and Generation X and the growing threat among youth could be linked to obesity, poor diet, environmental factors, lack of exercise and poor sleep. A study published in medical journal The Lancet reported an increase in diagnosis of 17 types of cancer in…

The Independent UK

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

Fortune

Here's the real reason Ozempic-like weight-loss drugs are so popular

Cohorts who were unresponsive to previous strategies like portion control may be responding to the new GLP 1 drugs.

The Guardian - UK

Majority in UK want new tax on makers of ultra-processed and junk food

Exclusive: Poll findings prompt calls for ministers to impose sugar tax-style levy on companies to combat obesity

The Times of India

Ozempic face to Ozempic butt; how weight loss drugs affect the body

Drugs like Ozempic and Wegovy with their promise to fight obesity effectively with around 15 to 20 per cent weight loss in its users, have been the talk of town ever since their launch in 2017 and 2021 respectively.

1 … 39 40 41 42

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.